Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Inventory (2018 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Inventory for 7 consecutive years, with $32.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 19.21% year-over-year to $32.9 million, compared with a TTM value of $32.9 million through Dec 2025, up 19.21%, and an annual FY2025 reading of $32.9 million, up 19.21% over the prior year.
  • Inventory was $32.9 million for Q4 2025 at Agios Pharmaceuticals, up from $32.0 million in the prior quarter.
  • Across five years, Inventory topped out at $32.9 million in Q4 2025 and bottomed at $2.5 million in Q1 2022.
  • Average Inventory over 4 years is $19.4 million, with a median of $21.1 million recorded in 2023.
  • The sharpest move saw Inventory surged 357.71% in 2023, then grew 19.21% in 2025.
  • Year by year, Inventory stood at $8.5 million in 2022, then soared by 124.63% to $19.1 million in 2023, then skyrocketed by 44.77% to $27.6 million in 2024, then rose by 19.21% to $32.9 million in 2025.
  • Business Quant data shows Inventory for AGIO at $32.9 million in Q4 2025, $32.0 million in Q3 2025, and $30.8 million in Q2 2025.